Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis
Diagnostics · 06.08.2025 · 15 (15) · 1972
DOI: 10.3390/diagnostics15151972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 06.08.2025. Verfasst von Anamaria Ardelean und 8 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Doctoral School, "Vasile Goldis" Western University of Arad, 310414 Arad, Romania. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Osteoporosis remains a leading cause of morbidity in postmenopausal women, yet many high-risk individuals remain undiagnosed or untreated. This study aimed to assess the prevalence of osteoporosis and osteopenia, treatment patterns, and skeletal fragility indicators in a large cohort of postmenopausal women undergoing DXA screening.
Methods
We analyzed data from 1669 postmenopausal women aged 40–89 years who underwent DXA evaluation. BMD status was categorized as normal, osteopenia, or osteoporosis. Treatment status was classified based on active antiosteoporotic therapy, calcium/vitamin D supplementation, hormonal therapy (historical use), or no treatment. Logistic regression models were used to explore independent predictors of osteoporosis and treatment uptake.
Results
A total of 45.0% of women had osteoporosis and 43.5% had osteopenia. Despite this, 58.5% of the population, over half of women with osteoporosis, were not receiving any active pharmacologic treatment. Bisphosphonates were the most prescribed therapy (17.9%), followed by calcium/vitamin D supplements (20.6%). A prior history of fragility fractures and radiological bone lesions were significantly associated with lower BMD (p < 0.05). Historical hormone replacement therapy (HRT) use was not associated with current BMD (p = 0.699), but women with HRT use reported significantly fewer fractures (p < 0.001). In multivariate analysis, later menopause age and low BMD status predicted higher odds of receiving active treatment.
Conclusions
Our findings highlight a substantial care gap in osteoporosis management, with treatment primarily initiated reactively in more severe cases. Improved screening and earlier intervention strategies are urgently needed to prevent fractures and reduce the long-term burden of osteoporosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multidisciplinary Doctoral School, "Vasile Goldis" Western University of Arad, 310414 Arad, Romania.
- Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
- Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
- Department Medicine, Faculty of Medicine, "Vasile Goldis" Western University of Arad, 310414 Arad, Romania.
- Department of Pathophysiology, Faculty of Medicine, "Vasile Goldis" Western University of Arad, 310414 Arad, Romania.
- Department of Psycho-neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
ORCID-Profile: Delia Mirela Tit
Zitieren
APA
Ardelean, A., Tit, D. M., Furau, R., Todut, O., Bungau, G. S., Pavel, R. M. S., Uivaraseanu, B., Bei, D. A., & Furau, C. (2025). Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis. Diagnostics, 15(15), 1972. https://doi.org/10.3390/diagnostics15151972
Vancouver
Ardelean A, Tit DM, Furau R, Todut O, Bungau GS, Pavel RMS, et al. Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis. Diagnostics. 2025;15(15):1972. doi:10.3390/diagnostics15151972
BibTeX
@article{Ardelean2025,
author = {Ardelean, Anamaria and Tit, Delia Mirela and Furau, Roxana and Todut, Oana and Bungau, Gabriela S and Pavel, Roxana Maria Sânziana and Uivaraseanu, Bogdan and Bei, Diana Alina and Furau, Cristian},
title = {Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {15},
pages = {1972},
doi = {10.3390/diagnostics15151972}
}
EUVIMED